• Join
  • Login
  • Contact

Search abstracts

New innovations in the clinico-molecular analysis of drug safety data

  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: JACKSON, David (Molecular Health GmbH, Heidelberg, Germany)
  • Co-author(s): David Jackson: Innovation, Molecular Health GmbH, Heidelberg, Germany
  • Abstract:


    Efforts to decipher the mechanisms controlling genotype to phenotype transition are critical to medical advancements, yet we still rely heavily on insights from model organisms. While the new high-throughput molecular technologies are providing insights directly from patients, progress is hindered by cost and privacy concerns. To complement


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses